Gastrointestinal disorders

Applied filters

Gastrointestinal disorders

COVID-19 Medicines Optimisation (1)
- COVID-19 Medicines Optimisation: Specialty Guidance (1)
Care Setting (3)
- Neonates (2)
- Paediatrics (1)
Guidance (112)
- Advanced therapy medicinal products (3)
- Dosing (2)
- Formulation (3)
- Medicines Safety (1)
- Safety in Breastfeeding (92)
- Safety in Pregnancy (4)
- Stability in dosette boxes (60)
- Stability outside the fridge (8)
- Swallowing difficulties (1)
Medicine (141)
- Adalimumab (2)
- Alendronic acid (1)
- Aluminium hydroxide (2)
- Aluminium hydroxide + Magnesium trisilicate (1)
- Alverine (1)
- Alverine + Simeticone (1)
- Amisulpride (1)
- Amoxicillin (1)
- Aprepitant (2)
- Arachis oil (1)
- Aspirin (1)
- Atropine (1)
- Azathioprine (1)
- Balsalazide (2)
- Beclometasone (2)
- Benralizumab (1)
- Benzyl benzoate (1)
- Betahistine (2)
- Bisacodyl (1)
- Budesonide (2)
- Chlorpromazine (2)
- Cholic acid (1)
- Ciclosporin (1)
- Cimetidine (2)
- Cinchocaine (1)
- Cinchocaine + Hydrocortisone (1)
- Cinnarizine (2)
- Clonidine (1)
- Co-danthramer (1)
- Co-magaldrox (2)
- Co-phenotrope (1)
- Codeine (2)
- Colestyramine (1)
- Cyclizine (2)
- Dantrolene (1)
- Dexamethasone (1)
- Dicycloverine (1)
- Diltiazem (1)
- Docusate (1)
- Domperidone (2)
- Doxycycline (1)
- Doxylamine + Pyridoxine (2)
- Dupilumab (1)
- Erythromycin (1)
- Esomeprazole (3)
- Famotidine (2)
- Filgotinib (1)
- Fosaprepitant (2)
- Glycerol (1)
- Golimumab (2)
- Granisetron (1)
- Guselkumab (1)
- Hydrocortisone (1)
- Hydrocortisone + Pramocaine (1)
- Hydrotalcite (2)
- Hyoscine butylbromide (1)
- Hyoscine hydrobromide (2)
- Ibandronic acid (1)
- Infliximab (1)
- Irinotecan (1)
- Ispaghula husk (1)
- Kaolin (1)
- Ketoprofen + Omeprazole (1)
- Lactulose (1)
- Lansoprazole (3)
- Linaclotide (1)
- Liquid paraffin (1)
- Liraglutide (1)
- Loperamide (2)
- Lubiprostone (1)
- Macrogol 3350 (1)
- Magnesium carbonate (2)
- Magnesium sulfate (1)
- Magnesium trisilicate (2)
- Mebendazole (1)
- Mebeverine (1)
- Menthol (1)
- Mercaptopurine (1)
- Mesalazine (2)
- Methotrexate (1)
- Methylcellulose (1)
- Methylnaltrexone bromide (1)
- Metoclopramide (2)
- Misoprostol (2)
- Nabilone (2)
- Naloxegol (1)
- Netupitant + Palonosetron (2)
- Nizatidine (2)
- Obeticholic acid (1)
- Olsalazine (1)
- Omeprazole (4)
- Ondansetron (2)
- Ozanimod (1)
- Palonosetron (2)
- Pancreatin (1)
- Pantoprazole (2)
- Peppermint oil (1)
- Perphenazine (2)
- Prednisolone (1)
- Prochlorperazine (2)
- Promethazine hydrochloride (2)
- Promethazine teoclate (1)
- Propantheline (1)
- Prucalopride (1)
- Rabeprazole (2)
- Ranitidine (2)
- Rifabutin (1)
- Risankizumab (1)
- Risedronate sodium (1)
- Risedronic acid (1)
- Salmeterol (1)
- Senna (1)
- Simeticone (2)
- Sodium acid phosphate + Sodium phosphate (1)
- Sodium alginate + Magnesium alginate (2)
- Sodium bicarbonate (3)
- Sodium chloride (3)
- Sodium citrate (1)
- Sodium picosulfate (1)
- Sucralfate (2)
- Sulfasalazine (2)
- Teduglutide (2)
- Tofacitinib (1)
- Trastuzumab (1)
- Trastuzumab emtansine (1)
- Trifluoperazine (2)
- Tripotassium dicitratobismuthate (2)
- Ursodeoxycholic acid (1)
- Ustekinumab (2)
- Vedolizumab (2)
- Wheat grain (1)
Planning (75)
- Biosimilars (2)
- New Medicines (59)
  - CCG commissioned new medicines (40)
  - NHS England commissioned new medicines (24)
  - Pre-registration new medicines (UK/EU) (9)
- Patent expiries (41)
Publications (1)
- RMOC recommendations and resources (1)
Specialty (163)
- Allergy and immunology (5)
- Anaesthesia and pain (5)
- Cancers (6)
- Cardiovascular system disorders (7)
- Diabetes (1)
- Ear, nose and throat disorders (7)
- Endocrine system disorders (1)
- Eyes and vision (5)
- Gastrointestinal disorders (163)
- Haematological disorders (2)
- Infection and infectious diseases (6)
- Liver disorders (1)
- Mental health and illness (20)
- Musculo-skeletal disorders (14)
- Neurological disorders (4)
- Nutritional and metabolic disorders (4)
- Obstetrics and gynaecology (3)
- Renal and urologic disorders (6)
- Respiratory disorders (7)
- Skin disorders (11)
- Surgery (1)

High dose loperamide use in high stoma output or short bowel syndrome

11 January 2022This guidance explores the dosing and monitoring advice when using high dose loperamide to reduce high stoma output or in short bowel syndrome in adults.

Nausea and Vomiting: treatment during pregnancy

6 January 2022Signposting evidence-based information on the treatment of nausea and vomiting in pregnancy

Constipation: treatment during pregnancy

6 January 2022Signposting evidence-based information on the treatment of constipation in pregnancy

Heartburn and Dyspepsia: treatment during pregnancy

6 January 2022Signposting evidence-based information on the treatment of heartburn and dyspepsia in pregnancy

Haemorrhoids: treatment during pregnancy

6 January 2022Signposting evidence-based information on the treatment of haemorrhoids in pregnancy

Sodium content of medicines for indigestion and gastric disorders

26 October 2021List of effervescent, soluble, dispersible and other preparations for treating indigestion and gastric disorders that could contain high levels of sodium.

Sodium content of medicines for constipation and diarrhoea

26 October 2021List of effervescent, soluble, dispersible and other preparations for treating constipation and diarrhoea that could contain high levels of sodium.

Considering sodium content of medicines

26 October 2021High sodium content can make some medicines unsuitable for patients on a salt-restricted diet. Alternative products exist for a range of conditions.

Proton pump inhibitor (PPI) formulations suggested for adults with swallowing difficulties

1 July 2021A range of proton pump inhibitors are suitable for adults with swallowing difficulties.

SPS - Specialist Pharmacy Service

NHS